Pcas SA represents values of innovation, integrity, and sustainability. The company's corporate philosophy is centered around delivering high-quality chemical solutions to their clients while minimizing environmental impact. Pcas SA believes in fostering strong relationships with customers, suppliers, and employees based on trust, reliability, and open communication. With a focus on research and development, Pcas SA continuously strives to develop cutting-edge technologies and stay ahead of market trends. By maintaining a commitment to ethical business practices and social responsibility, Pcas SA aims to create long-term value for its stakeholders while contributing to a more sustainable future.

Pcas SA is primarily present in France and Belgium.

Pcas SA, a leading company in the stock market, has achieved several significant milestones. Over the years, Pcas SA has demonstrated remarkable growth, becoming a key player in the industry. This company has successfully expanded its market share, attracted new investors, and consistently delivered strong financial performance. Pcas SA's dedication to innovation, unwavering commitment to customer satisfaction, and strategic partnerships have been instrumental in its success. By continually adapting to changing market dynamics and leveraging its expertise, Pcas SA has positioned itself as a reliable and competitive stock option for investors seeking long-term growth and profitability.

Pcas SA, a prominent company in the stock market, has a rich history and background. Established in [year], Pcas SA has built a strong reputation in the [industry] sector. With its headquarters in [location], the company has demonstrated consistent growth and success over the years. Pcas SA specializes in [specific products/services], providing innovative solutions to various industries. Its commitment to excellence, combined with a talented team of professionals and advanced technologies, has contributed to its continuous expansion and market leadership. The company's unwavering dedication to customer satisfaction and its ability to adapt to changing market trends have solidified Pcas SA's position as a leading player in the industry.

The main competitors of Pcas SA in the market are companies such as SFC Co, XYZ Corp, and ABC Ltd. These companies operate in the same industry and offer similar products and services as Pcas SA. Despite competition, Pcas SA distinguishes itself through its innovative technologies, cutting-edge research, and excellent customer service. With its strong market presence and strategic partnerships, Pcas SA continues to stay ahead of its competitors and maintain a strong position in the industry.

Pcas SA is primarily active in the chemical industry.

The business model of Pcas SA revolves around providing custom manufacturing and R&D services for specialty chemicals and pharmaceutical intermediates. Pcas SA specializes in developing, producing, and selling niche molecules and advanced chemical solutions for various industries, including pharmaceuticals, cosmetics, agrochemicals, and electronics. The company focuses on offering tailored solutions to meet specific customer needs, leveraging its expertise in synthesis, purification, and formulation. By emphasizing technological innovation and sustainable practices, Pcas SA aims to maintain its competitive edge and deliver high-quality products to its clients worldwide.

The P/E ratio cannot be calculated for Pcas at the moment.

The P/S cannot be calculated for Pcas currently.

The AlleAktien quality score for Pcas is 4/10.

The revenue cannot currently be calculated for Pcas.

The profit cannot currently be calculated for Pcas.

The company Pcas SA is a leading provider of innovative solutions and services in the pharmaceutical and chemical industry. Its business model is based on providing high-quality products and services tailored to the specific requirements of customers. Pcas SA operates in various sectors, including the production of active ingredients, the development of specialized chemicals, and the production of pharmaceutical intermediates. The company also offers contract research and development services and supports customer projects with individualized services. Pcas SA has a wide range of products and the ability to develop customized solutions that meet the specific needs of its customers. It has a modern research and development facility and works closely with customers to develop innovative and tailored solutions. One of the main sectors of Pcas SA is the production of active ingredients, which are important components in the production of drugs for the treatment of diseases such as cancer, heart diseases, and inflammations. Another important area of Pcas SA is the development and production of specialized chemicals, which are key for the production of various end products, such as cosmetics, food additives, and agricultural usage. Pcas SA also offers customized solutions in the field of contract research and development. The company works closely with customers to develop individualized offers that meet their specific requirements. The results of research and development can then be used as inputs for further production or processing of drugs. In summary, Pcas SA pursues an innovative business model by offering high-quality products and tailored solutions for the demanding pharmaceutical and chemical industry. The focus on research and development and the close customer contact distinguish the company and enable Pcas SA to differentiate itself in a competitive market and achieve future growth.

Pcas pays a dividend of 0 EUR distributed over payouts per year.

The dividend cannot currently be calculated for Pcas or the company does not pay out a dividend.

The ISIN of Pcas is FR0000053514.

The WKN of Pcas is 936292.

The ticker of Pcas is PCA.PA.

Over the past 12 months, Pcas paid a dividend of 0.06 EUR . This corresponds to a dividend yield of about 0.75 %. For the coming 12 months, Pcas is expected to pay a dividend of 0 EUR.

The current dividend yield of Pcas is 0.75 %.

Pcas pays a quarterly dividend. This is distributed in the months of October, May, October, August.

Pcas paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

Pcas is assigned to the 'Health' sector.

To receive the latest dividend of Pcas from 7/5/2017 amounting to 0.06 EUR, you needed to have the stock in your portfolio before the ex-date on 7/3/2017.

The last dividend was paid out on 7/5/2017.

In the year 2023, Pcas distributed 0 EUR as dividends.

The dividends of Pcas are distributed in EUR.